Viridian Therapeutics (UK) Price on September 11, 2024
| 0K1R Stock | 15.70 0.08 0.51% |
Below is the normalized historical share price chart for Viridian Therapeutics extending back to January 24, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Viridian Therapeutics stands at 15.70, as last reported on the 27th of February, with the highest price reaching 15.87 and the lowest price hitting 15.56 during the day.
If you're considering investing in Viridian Stock, it is important to understand the factors that can impact its price. Viridian Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0789, which indicates the firm had a -0.0789 % return per unit of risk over the last 3 months. Viridian Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Viridian Therapeutics' Risk Adjusted Performance of (0.04), coefficient of variation of (1,485), and Variance of 24.21 to confirm the risk estimate we provide.
Total Stockholder Equity is likely to gain to about 533.7 M in 2025. Common Stock Shares Outstanding is likely to gain to about 54 M in 2025. Viridian Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 19.5281 | 50 Day MA 20.0191 | Beta 1.35 |
Viridian |
Sharpe Ratio = -0.0789
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 0K1R |
Estimated Market Risk
| 5.02 actual daily | 44 56% of assets are more volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Viridian Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Viridian Therapeutics by adding Viridian Therapeutics to a well-diversified portfolio.
Related Headline
Erste Group Headline on 11th of September 2024
Erste Group raises AstraZeneca stock to Buy on strong pipeli... by news.google.com
Erste Group raises AstraZeneca stock to Buy on strong pipeline Investing.com
Viridian Therapeutics Valuation on September 11, 2024
It is possible to determine the worth of Viridian Therapeutics on a given historical date. On September 11, 2024 Viridian was worth 18.35 at the beginning of the trading date compared to the closed value of 20.54. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Viridian Therapeutics stock. Still, in general, we apply an absolute valuation method to find Viridian Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Viridian Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Viridian Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 13.39 | 17.71 | 12.32 | 17.55 | 80,913 | |
09/11/2024 | 18.35 | 20.54 | 17.83 | 20.54 | 67,534 |
| 19.89 | 22.20 | 19.67 | 21.47 | 44,314 |
| Backtest Viridian Therapeutics | | | Viridian Therapeutics History | | | Viridian Therapeutics Valuation | Previous | Next |
Viridian Therapeutics Trading Date Momentum on September 11, 2024
| On September 12 2024 Viridian Therapeutics was traded for 21.47 at the closing time. The highest price during the trading period was 22.20 and the lowest recorded bid was listed for 19.67 . The volume for the day was 44.3 K. This history from September 12, 2024 contributed to the next trading day price appreciation. The daily price change to the next closing price was 4.53% . The trading price change to the current price is 8.86% . |
Viridian Therapeutics Fundamentals Correlations and Trends
By evaluating Viridian Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Viridian Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Viridian financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Viridian Therapeutics Stock history
Viridian Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Viridian is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Viridian Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Viridian Therapeutics stock prices may prove useful in developing a viable investing in Viridian Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.5 M | 54 M | |
| Net Loss | -116.9 M | -111 M |
Viridian Therapeutics Stock Technical Analysis
Viridian Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Viridian Therapeutics Period Price Range
Low | February 27, 2025
| High |
0.00 | 0.00 |
Viridian Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on London Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Viridian Therapeutics February 27, 2025 Market Strength
Market strength indicators help investors to evaluate how Viridian Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Viridian Therapeutics shares will generate the highest return on investment. By undertsting and applying Viridian Therapeutics stock market strength indicators, traders can identify Viridian Therapeutics entry and exit signals to maximize returns
Viridian Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Viridian Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Viridian Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Viridian to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.30) | |||
| Treynor Ratio | 1.02 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Viridian Stock Analysis
When running Viridian Therapeutics' price analysis, check to measure Viridian Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viridian Therapeutics is operating at the current time. Most of Viridian Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viridian Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viridian Therapeutics' price. Additionally, you may evaluate how the addition of Viridian Therapeutics to your portfolios can decrease your overall portfolio volatility.